Dr. Shaun Chandna, DO

Dr. Chandna practices at Olive View-UCLA Medical Center in Sylmar, California, part of County of Los Angeles.

Dr. Chandna's NPI, 1497989719, was assigned on May 14, 2009. Dr. Chandna graduated from WesternU College of Osteopathic Medicine of the Pacific in 2009. Dr. Chandna holds Utah license 10552711-1204.

Dr. Chandna's primary practice is Olive View-UCLA Medical Center, at 14445 Olive View Drive, Sylmar, CA 91342 in Los Angeles County. The practice phone is (818) 364-1555.

Dr. Chandna's primary practice is Olive View-UCLA Medical Center in Sylmar, California, part of County of Los Angeles. Dr. Chandna is also affiliated with University of Utah Hospital. The medical group on file is University of Utah Health. Dr. Chandna's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chandna practices, 2 sites in all. Vendor and product names are available with a free account.

Transplant hepatology is Dr. Chandna's primary specialty in the NPI Registry, under taxonomy code 207RT0003X. Dr. Chandna is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Chandna's licenses on file in 3 states: Utah, Ohio and Washington.

Dmand AI lists cirrhosis of the liver, colonoscopy, fatty liver, hepatitis c and upper GI endoscopy among the conditions Dr. Chandna treats.

CMS data shows 264 Medicare services from Dr. Chandna across 6 procedure codes in 2023, for 20 Medicare patients. Medicare paid $21,128 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 20 Medicare patients who saw Dr. Chandna in 2024. 75% of them have high blood pressure, and 70% have diabetes. Their average risk score is 3.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chandna's median patient age at 58, with 52% women.

In 2024, Dr. Chandna wrote 272 Medicare Part D claims for 79 patients. 82% of them were for generic drugs. CMS names the drug for 191 of them, across 10 drugs with 11 or more claims each, at $161,819 in total drug cost. In 2023, CMS named 458 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Chandna for performance year 2024, reported as part of a group.

Dmand AI links 7 papers to Dr. Chandna, published from 2019 to 2024. 2019 was the busiest year, with 2. The most frequent topics are Liver Transplantation. Dr. Chandna's most frequent co-authors are Avegail Gascon Flores, MD, Catherine Therese Frenette, MD and Prasun K. Jalal, MD.

Dmand AI links Dr. Chandna to 1 clinical trial. Conditions studied include alpha 1-Antitrypsin Deficiency and Subcutaneous Emphysema.

CMS Open Payments shows 102 general payments to Dr. Chandna from 17 drug and device companies from 2018 to 2025. Speaker and faculty fees make up the largest share, 66% of the total. Madrigal Pharmaceuticals paid the most, $37,353.

Dmand AI lists 4 awards for Dr. Chandna, most recently Graduate Medical Trainee Award of Excellence in 2015. Dr. Chandna serves on American Liver Foundation.

Dr. Chandna graduated from WesternU College of Osteopathic Medicine of the Pacific in 2009. Dr. Chandna is a member of American Association for the Study of Liver Diseases, ACG, ACP, AGA and AMA.

Dr. Chandna is in network with 8 carriers, including Cigna, Molina and United Healthcare. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.